CardiaCare has developed the world's first wearable therapy for treating Atrial Fibrillation. Despite new therapies, Atrial fibrillation (AFib) is still the most common sustained arrhythmia and is considered a rising epidemic affecting millions of people world wide. CardiaCare technology utilizes noninvasive peripheral neuromodulation to mediate a cardiovascular anti arrhythmic response that reduces atrial fibrillation burden. The technology employs a closed loop approach involving both monitoring and therapy. With expert leadership and enthusiastic investors CardiaCare is now planning it’s first regulatory human clinical trial.
Company Details
- Employees
- 9
- Founded
- -
- Address
- 8 Pinchas Sapir St, Ness Tsiona,israel 6082365,israel
- in****@****are.com
- Industry
- Medical Equipment Manufacturing
- NAICS
-
Medical Equipment and Supplies ManufacturingSurgical and Medical Instrument ManufacturingSurgical Appliance and Supplies ManufacturingDental Equipment and Supplies ManufacturingOphthalmic Goods ManufacturingDental Laboratories
- Website
- my-cardiacare.com
- HQ
- Ness Tsiona , israel
Cardiacare Questions
Cardiacare's website is my-cardiacare.com
Cardiacare's LinkedIn profile is https://il.linkedin.com/company/cardiacare
Cardiacare has
9 employees.
View email and phone details for 9
employees at Cardiacare.
Cardiacare's industry is
Medical Equipment Manufacturing
Cardiacare's top competitors are
Yourrhythmics,
Implicity,
Irhythm Technologies, Inc.,
Meacor,
Acarix,
Hemasense,
Happitech,
Vektor Medical, Inc.,
Heartbeam Inc. (Nasdaq: Beat),
Accurkardia.
Cardiacare's support email address is info@my-cardiacare.com
Cardiacare's categories are Medical Equipment Manufacturing
Cardiacare's founding year is 2015
